Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo

BACKGROUND: Dendritic cell (DC) targeted antigen delivery is a promising strategy to enhance vaccine efficacy and delivery of therapeutics. Self-assembling peptide-based nanoparticles and virus-like particles (VLPs) have attracted extensive interest as non-replicating vectors for nanovaccine design,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ying, Liu, Ze-Hui, Li, Ying-Xiang, Xu, Hui-Ling, Fang, Wei-Huan, He, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994610/
https://www.ncbi.nlm.nih.gov/pubmed/35411142
http://dx.doi.org/10.2147/IJN.S357462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994610/
https://www.ncbi.nlm.nih.gov/pubmed/35411142
http://dx.doi.org/10.2147/IJN.S357462

Ejemplares similares